Zomedica Corp. (ZOMDF)

Zomedica Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8.84	7.02	12.95	27.4	194.95	61.99
Short-Term Investments	54.77	64.33	77.55	87.69	-	-
Cash & Short-Term Investments	63.61	71.35	90.5	115.09	194.95	61.99
Cash Growth	-23.33%	-21.15%	-21.37%	-40.96%	214.48%	3915.48%
Accounts Receivable	1.57	2.42	1.2	0.6	0.32	-
Other Receivables	0.56	0.65	1	1.27	0.45	0.15
Receivables	2.12	3.07	2.2	1.86	0.77	0.15
Inventory	5.36	5.06	5.12	2.75	2.85	-
Prepaid Expenses	2.14	2.29	2.06	3.8	1.84	1.73
Total Current Assets	73.22	81.77	99.88	123.5	200.41	63.87
Property, Plant & Equipment	24.73	26.2	25.29	9.17	2.87	1.9
Long-Term Investments	0.97	-	10.01	40.71	-	-
Goodwill	-	45.56	61.58	63.98	43.29	-
Other Intangible Assets	42.77	52.54	55.36	41.8	33.18	0.36
Other Long-Term Assets	1.31	1.29	1.07	0.45	0.66	0.01
Total Assets	142.99	207.36	253.2	279.61	280.4	66.14
Accounts Payable	2.3	1.93	2.07	6.7	3.23	1.25
Accrued Expenses	3.78	6.1	5.35	-	-	-
Short-Term Debt	-	-	-	-	-	0.53
Current Portion of Leases	0.67	0.52	0.92	0.64	0.42	0.25
Current Income Taxes Payable	0.14	0.12	0.07	0.19	0.24	-
Current Unearned Revenue	0.32	0.33	0.28	0.21	0.2	-
Other Current Liabilities	0.2	0.34	0.36	0.08	0.26	-
Total Current Liabilities	7.41	9.33	9.03	7.81	4.34	2.03
Long-Term Leases	2.01	1.29	1.81	1.1	0.96	1.09
Long-Term Unearned Revenue	0.25	0.22	0.25	0.18	0.14	-
Long-Term Deferred Tax Liabilities	0.44	0.46	1.14	1.25	3.71	-
Other Long-Term Liabilities	0.45	0.4	0.94	1.88	0.36	-
Total Liabilities	10.55	11.7	13.18	12.22	9.51	3.12
Common Stock	380.97	380.97	380.97	380.97	380.96	104.78
Additional Paid-In Capital	33.06	32.52	29.93	23.67	9.31	14.79
Retained Earnings	-281.72	-217.92	-170.93	-136.4	-119.39	-68.97
Comprehensive Income & Other	0.13	0.09	0.05	-0.84	0	0.46
Total Common Equity	132.44	195.66	240.02	267.39	270.89	51.07
Shareholders' Equity	132.44	195.66	240.02	267.39	270.89	63.03
Total Liabilities & Equity	142.99	207.36	253.2	279.61	280.4	66.14
Total Debt	2.68	1.81	2.73	1.74	1.38	1.87
Net Cash (Debt)	60.93	69.54	87.77	113.35	193.57	60.12
Net Cash Growth	-24.27%	-20.77%	-22.57%	-41.44%	221.96%	3794.47%
Net Cash Per Share	0.06	0.07	0.09	0.12	0.20	0.16
Filing Date Shares Outstanding	979.95	979.95	979.95	979.95	979.9	947.3
Total Common Shares Outstanding	979.95	979.95	979.95	979.95	979.9	642.04
Working Capital	65.82	72.44	90.85	115.69	196.07	61.84
Book Value Per Share	0.14	0.20	0.24	0.27	0.28	0.08
Tangible Book Value	89.68	97.57	123.07	161.61	194.42	50.7
Tangible Book Value Per Share	0.09	0.10	0.13	0.16	0.20	0.08
Machinery	16.42	17.03	10.44	6.85	1.73	0.72
Construction In Progress	6.6	7.89	12.48	0.69	0.42	-
Leasehold Improvements	2.81	3.09	1.95	1.24	0.29	0.57

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.